NCT06599268

Brief Summary

Research into the barriers and enablers for women's advancement in the pharmaceutical sector highlights several key factors. On the one hand, systemic issues such as gender bias, the glass ceiling, and the lack of adequate mentorship prevent many women from reaching executive roles. These barriers are often compounded by societal expectations, family responsibilities, and the rigid structures of work environments that disproportionately affect women. On the other hand, enabling factors like strong mentorship, diversity policies, leadership development programs, and workplace flexibility have proven to help women overcome these challenges and climb the corporate ladder. Companies that actively promote inclusive cultures and provide opportunities for women to develop leadership skills have seen greater success in gender diversity at the executive level. Understanding the dynamics of women's leadership in pharmaceuticals is particularly relevant in regions like Lebanon, where cultural and social norms heavily influence gender roles. Although women in Lebanon are increasingly pursuing careers in healthcare and pharmaceuticals, few reach executive positions due to a combination of cultural expectations and structural limitations within companies. Analyzing the barriers and enablers for women's leadership in this context is crucial, as Lebanon's healthcare and pharmaceutical sectors play a vital role in the country's economy and well-being. Including women in leadership roles could enhance decision-making, foster innovation, and lead to more balanced workplace environments. Moreover, in a country with a history of political instability and economic challenges, addressing gender disparity in leadership becomes not just a matter of equality but one of economic necessity. Women bring diverse perspectives and leadership styles that can help companies navigate complex markets, drive performance, and foster sustainability. In the Lebanese pharmaceutical sector, where the demand for skilled professionals and innovative leadership is high, unlocking the potential of women in executive roles can lead to more resilient and adaptable organizations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 4, 2025

Status Verified

March 1, 2025

Enrollment Period

4 months

First QC Date

September 11, 2024

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Correlation between the score of the schemes, as mentioned earlier, and the participants general characteristics.

    The likert scale per scheme will be transformed into a score and associated with the participants characteristics

    through study completion, an average of 3 months

Study Arms (1)

Pharmacists

Pharmacists/Pharmacy Students working in pharmaceutical companies or communities among others

Behavioral: Survey using a questionnaire.

Interventions

Questionnaire to assess the barriers and enablers for women reaching top executive positions in pharmaceutical companies and pharmacies The following sections will be considered: * General Characteristics of the Participants * Work-related characteristics * Barriers faced by women to reach top executive positions (Likert scale) * Enablers for women to reach top executive positions (Likert scale) * Conception of women in the pharmaceutical sector (Likert scale)

Pharmacists

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pharmacists/Pharmacy Students working in pharmaceutical companies

You may qualify if:

  • Pharmacists/Pharmacy Students
  • Working in companies/Community pharmacies

You may not qualify if:

  • Non-Lebanese
  • Those unemployed or Free-lancer
  • Those working for companies outside Lebanon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lebanese University

Beirut, 0000, Lebanon

Location

Study Officials

  • Georges Hatem

    Lebanese University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Researcher

Study Record Dates

First Submitted

September 11, 2024

First Posted

September 19, 2024

Study Start

July 15, 2024

Primary Completion

November 15, 2024

Study Completion

December 30, 2024

Last Updated

March 4, 2025

Record last verified: 2025-03

Locations